Chow LQM. Head and neck cancer. New England Journal of Medicine 2020; 382(1):60–72. doi:10.1056/NEJMra1715715
Son E, Panwar A, Mosher CH, Lydiatt D. Cancers of the major salivary gland. Journal of Oncology Practice 2018; 14(2):99–108.
[PubMed Abstract]Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. International Journal of Cancer 2008; 122(1):155–164.
[PubMed Abstract]Hashibe M, Boffetta P, Zaridze D, et al. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiology, Biomarkers and Prevention 2006; 15(4):696–703.
[PubMed Abstract]Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Journal of the National Cancer Institute 2007; 99(10):777–789.
[PubMed Abstract]Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. The Lancet Oncology 2008; 9(7):667–675.
[PubMed Abstract]Mariano LC, Warnakulasuryia S, Straif K, Monteiro L. Secondhand smoke exposure and oral cancer risk: A systematic review and meta-analysis. Tobacco Control 2021:tobaccocontrol-2020-056393. doi: 10.1136/tobaccocontrol-2020-056393.
[PubMed Abstract]Hashim D, Genden E, Posner M, Hashibe M, Boffetta P. Head and neck cancer prevention: From primary prevention to impact of clinicians on reducing burden. Annals of Oncology 2019; 30(5):744–756.
[PubMed Abstract]Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers and Prevention 2009; 18(2):541–550.
[PubMed Abstract]Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology 2011; 29(32)4294–4301.
[PubMed Abstract]Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. Head and Neck 2009; 31(11):1393–1422.
[PubMed Abstract]Gillison ML, D’Souza G, Westra W, et al. Distinct risk factors profiles for human papillomavirus type 16-positive and human papillomavirus type-16 negative head and neck cancers. Journal of the National Cancer Institute 2008; 100(6):407–420.
[PubMed Abstract]Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. Journal of the National cancer Institute 2015; 107(6):djv086. doi: 10.1093/jnci/djv086.
[PubMed Abstract]Senkomago V, Henley SJ, Thomas CC, et al. Human papillomavirus-attributable cancers - United States, 2012–2016. MMWR. Morbidity and Mortality Weekly Report 2019; 68(33):724–728.
[PubMed Abstract]Ho PS, Ko YC, Yang YH, Shieh TY, Tsai CC. The incidence of oropharyngeal cancer in Taiwan: An endemic betel quid chewing area. Journal of Oral Pathology and Medicine 2002; 31(4):213–219.
[PubMed Abstract]Goldenberg D, Lee J, Koch WM, et al. Habitual risk factors for head and neck cancer. Otolaryngology and Head and Neck Surgery 2004; 131(6):986–993.
[PubMed Abstract]Yu MC, Yuan JM. Nasopharyngeal Cancer. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press, 2006.
Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Seminars in Cancer Biology 2002; 12(6):421–429.
[PubMed Abstract]Olshan AF. Cancer of the Larynx. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press, 2006.
Boffetta P, Richiardi L, Berrino F, et al. Occupation and larynx and hypopharynx cancer: An international case–control study in France, Italy, Spain, and Switzerland. Cancer Causes and Control 2003; 14(3):203–212.
[PubMed Abstract]Littman AJ, Vaughan TL. Cancers of the Nasal Cavity and Paranasal Sinuses. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press, 2006.
Luce D, Leclerc A, Bégin D, et al. Sinonasal cancer and occupational exposures: A pooled analysis of 12 case–control studies. Cancer Causes and Control 2002; 13(2):147–157.
[PubMed Abstract]Luce D, Gérin M, Leclerc A, et al. Sinonasal cancer and occupational exposure to formaldehyde and other substances. International Journal of Cancer 1993; 53(2):224–231.
[PubMed Abstract]Mayne ST, Morse DE, Winn DM. Cancers of the Oral Cavity and Pharynx. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press, 2006.
Preston-Martin S, Thomas DC, White SC, Cohen D. Prior exposure to medical and dental x-rays related to tumors of the parotid gland. Journal of the National Cancer Institute 1988; 80(12):943–949.
[PubMed Abstract]Horn-Ross PL, Ljung BM, Morrow M. Environmental factors and the risk of salivary gland cancer. Epidemiology 1997; 8(4):414–429.
[PubMed Abstract]Chien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. New England Journal of Medicine 2001; 345(26):1877–1882.
[PubMed Abstract]Hamilton-Dutoit SJ, Therkildsen MH, Neilsen NH, et al. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: Demonstration of Epstein-Barr virus DNA by in situ nucleic acid hybridization. Human Pathology 1991; 22(8):811–815.
[PubMed Abstract]Chan JK, Yip TT, Tsang WY, et al. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland. Archives of Pathology and Laboratory Medicine 1994; 118(10):994–997.
[PubMed Abstract]Beddok A, Krieger S, Castera L, Stoppa-Lyonnet D, Thariat J. Management of Fanconi anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation. Oral Oncology 2020; 108:104816.
[PubMed Abstract]Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA: A Cancer Journal for Clinicians 2021; 71(1):7–33.
[PubMed Abstract]Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine 2010; 363(1):24–35.
[PubMed Abstract]Strojan P, Hutcheson KA, Eisbruch A, et al. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer Treatment Reviews 2017;59:79–92.
[PubMed Abstract]Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: Joint effects of smoking and alcohol (United States). Cancer Causes and Control 2003; 14(2):131–138.
[PubMed Abstract]Argiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clinical Cancer Research 2004; 10(6)1956–1962.
[PubMed Abstract]Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. International Journal of Cancer 2008; 123(10):2390–2396.
[PubMed Abstract]